References
1. Lu, H.Y., et al., Contribution of Histologic Chorioamnionitis
and Fetal Inflammatory Response Syndrome to Increased Risk of Brain
Injury in Infants With Preterm Premature Rupture of Membranes. Pediatr
Neurol, 2016. 61 : p. 94-98.e1.
2. Lorthe, E., et al., Impact of Latency Duration on the Prognosis
of Preterm Infants after Preterm Premature Rupture of Membranes at 24 to
32 Weeks’ Gestation: A National Population-Based Cohort Study. J
Pediatr, 2017. 182 : p. 47-52.e2.
3. Tita, A.T. and W.W. Andrews, Diagnosis and management of
clinical chorioamnionitis. Clin Perinatol, 2010. 37 (2): p.
339-54.
4. Been, J.V., et al., Histologic chorioamnionitis, fetal
involvement, and antenatal steroids: effects on neonatal outcome in
preterm infants. Am J Obstet Gynecol, 2009. 201 (6): p.
587.e1-8.
5. Park, C.W., et al., The involvement of human amnion in
histologic chorioamnionitis is an indicator that a fetal and an
intra-amniotic inflammatory response is more likely and severe: clinical
implications. Placenta, 2009. 30 (1): p. 56-61.
6. Lahra, M.M. and H.E. Jeffery, A fetal response to
chorioamnionitis is associated with early survival after preterm birth.Am J Obstet Gynecol, 2004. 190 (1): p. 147-51.
7. Edwards, R.K. and P. Duff, Single additional dose postpartum
therapy for women with chorioamnionitis. Obstet Gynecol, 2003.102 (5 Pt 1): p. 957-61.
8. Kim, S.A., K.H. Park, and S.M. Lee, Non-Invasive Prediction of
Histologic Chorioamnionitis in Women with Preterm Premature Rupture of
Membranes. Yonsei Med J, 2016. 57 (2): p. 461-8.
9. Goldenberg, R.L., et al., Epidemiology and causes of preterm
birth. Lancet, 2008. 371 (9606): p. 75-84.
10. Goldenberg, R.L. and L.L. Wright, Repeated courses of
antenatal corticosteroids. Obstet Gynecol, 2001. 97 (2): p.
316-7.
11. Danesh, A., M. Janghorbani, and S. Khalatbari, Effects of
antenatal corticosteroids on maternal serum indicators of infection in
women at risk for preterm delivery: A randomized trial comparing
betamethasone and dexamethasone. J Res Med Sci, 2012. 17 (10):
p. 911-7.
12. Bauer, M.E., et al., Maternal leukocytosis after antenatal
corticosteroid administration: a systematic review and meta-analysis().J Obstet Gynaecol, 2018. 38 (2): p. 210-216.
13. Voon, H.Y., et al., Corticosteroid-induced leukocytosis in
pregnancy: A prospective observational study. Med J Malaysia, 2017.72 (5): p. 259-263.
14. Hu, Y., et al., Establishment of reference intervals for
procalcitonin in healthy pregnant women of Chinese population. Clin
Biochem, 2017. 50 (3): p. 150-154.
15. Areia, A.L., M. Areia, and A. Mota-Pinto, Procalcitonin in
preterm rupture of membranes: a systematic review and meta-analysis.Arch Gynecol Obstet, 2021. 303 (4): p. 917-924.
16. Thornburg, L.L., et al., Procalcitonin for prediction of
chorioamnionitis in preterm premature rupture of membranes. J Matern
Fetal Neonatal Med, 2016. 29 (13): p. 2056-61.
17. Li, K., et al., Predictive value of procalcitonin or
c-reactive protein for subclinical intrauterine infection in patients
with premature rupture of membranes (PROM). J Prenat Med, 2016.10 (3-4): p. 23-28.
18. Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number
217. Obstet Gynecol, 2020. 135 (3): p. e80-e97.
19. Yoon, B.H., et al., Amniotic fluid interleukin-6: a sensitive
test for antenatal diagnosis of acute inflammatory lesions of preterm
placenta and prediction of perinatal morbidity. Am J Obstet Gynecol,
1995. 172 (3): p. 960-70.
20. Asadi, N., et al., Predictive value of procalcitonin,
C-reactive protein, and white blood cells for chorioamnionitis among
women with preterm premature rupture of membranes. Int J Gynaecol
Obstet, 2019. 147 (1): p. 83-88.
21. Erdemir, G., et al., Histological chorioamnionitis: effects on
premature delivery and neonatal prognosis. Pediatr Neonatol, 2013.54 (4): p. 267-74.
22. Cobo, T., et al., A prediction model of histological
chorioamnionitis and funisitis in preterm prelabor rupture of membranes:
analyses of multiple proteins in the amniotic fluid. J Matern Fetal
Neonatal Med, 2012. 25 (10): p. 1995-2001.
23. Elimian, A., et al., Histologic chorioamnionitis, antenatal
steroids, and perinatal outcomes. Obstet Gynecol, 2000. 96 (3):
p. 333-6.
24. Denison, F.C., C.L. Elliott, and E.M. Wallace,Dexamethasone-induced leucocytosis in pregnancy. Br J Obstet
Gynaecol, 1997. 104 (7): p. 851-3.